Global Ankylosing Spondylitis Treatment Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 92

Report ID: 1065

Ankylosing spondylitis is a chronic inflammatory disease that affects the spine. It is a type of arthritis, in which spine bones grow or fuse together, causing the spine to become rigid. Symptoms of ankylosing spondylitis include pain and stiffness from the neck to the lower back, bony fusion, and pain in the ligaments and tendons. These symptomatic changes may be mild or severe, and may lead to a stooped-over posture. The prevalence of ankylosing spondylitis is seen in about 0.1% to 0.5% of the adult population worldwide. It can occur at any age irrespective of gender; however, higher prevalence has been observed among males between the ages of 15–30 years. 
The ankylosing spondylitis treatment market is growing at a significant rate due to the increasing prevalence of ankylosing spondylitis and rising awareness about diagnostics and treatments for the disease. In addition, government initiatives and improving healthcare infrastructure are driving the market for ankylosing spondylitis treatment. However, factors such as the high cost of treatment and lack of skilled surgeons and physiotherapists restrain the market from growing.
The increasing prevalence of ankylosing spondylitis itself is a major factor impelling the global ankylosing spondylitis treatment market. In addition, factors such as rising awareness, technological advancements, government initiatives and improvement in the reimbursement scenario augur well for the global ankylosing spondylitis treatment market. However, factors such as high treatment costs and a dearth of experienced professionals are restraining the global ankylosing spondylitis treatment market. In addition, a low adoption rate of ankylosing spondylitis treatment options is restraining the market.
In 2018, the global Ankylosing Spondylitis Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Ankylosing Spondylitis Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Ankylosing Spondylitis Treatment development in United States, Europe and China.

The key players covered in this study
Abbvie
Amgen
Janssen Biotech
Merck
UCB
Boehringer Ingelheim
Johnson & Johnson
...

Market segment by Type, the product can be split into
Disease-Modifying Anitrheumatic Drugs (DMARDs)
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Biologics

Market segment by Application, split into
Juveniles
Adults

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Ankylosing Spondylitis Treatment status, future forecast, growth opportunity, key market and key players.
To present the Ankylosing Spondylitis Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Ankylosing Spondylitis Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Ankylosing Spondylitis Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Disease-Modifying Anitrheumatic Drugs (DMARDs)
1.4.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
1.4.4 Biologics
1.5 Market by Application
1.5.1 Global Ankylosing Spondylitis Treatment Market Share by Application (2014-2025)
1.5.2 Juveniles
1.5.3 Adults
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Ankylosing Spondylitis Treatment Market Size
2.2 Ankylosing Spondylitis Treatment Growth Trends by Regions
2.2.1 Ankylosing Spondylitis Treatment Market Size by Regions (2014-2025)
2.2.2 Ankylosing Spondylitis Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Ankylosing Spondylitis Treatment Market Size by Manufacturers
3.1.1 Global Ankylosing Spondylitis Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Ankylosing Spondylitis Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Ankylosing Spondylitis Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Ankylosing Spondylitis Treatment Key Players Head office and Area Served
3.3 Key Players Ankylosing Spondylitis Treatment Product/Solution/Service
3.4 Date of Enter into Ankylosing Spondylitis Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Ankylosing Spondylitis Treatment Market Size by Type (2014-2019)
4.2 Global Ankylosing Spondylitis Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Ankylosing Spondylitis Treatment Market Size (2014-2019)
5.2 Ankylosing Spondylitis Treatment Key Players in United States
5.3 United States Ankylosing Spondylitis Treatment Market Size by Type
5.4 United States Ankylosing Spondylitis Treatment Market Size by Application

6 Europe
6.1 Europe Ankylosing Spondylitis Treatment Market Size (2014-2019)
6.2 Ankylosing Spondylitis Treatment Key Players in Europe
6.3 Europe Ankylosing Spondylitis Treatment Market Size by Type
6.4 Europe Ankylosing Spondylitis Treatment Market Size by Application

7 China
7.1 China Ankylosing Spondylitis Treatment Market Size (2014-2019)
7.2 Ankylosing Spondylitis Treatment Key Players in China
7.3 China Ankylosing Spondylitis Treatment Market Size by Type
7.4 China Ankylosing Spondylitis Treatment Market Size by Application

8 Japan
8.1 Japan Ankylosing Spondylitis Treatment Market Size (2014-2019)
8.2 Ankylosing Spondylitis Treatment Key Players in Japan
8.3 Japan Ankylosing Spondylitis Treatment Market Size by Type
8.4 Japan Ankylosing Spondylitis Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Ankylosing Spondylitis Treatment Market Size (2014-2019)
9.2 Ankylosing Spondylitis Treatment Key Players in Southeast Asia
9.3 Southeast Asia Ankylosing Spondylitis Treatment Market Size by Type
9.4 Southeast Asia Ankylosing Spondylitis Treatment Market Size by Application

10 India
10.1 India Ankylosing Spondylitis Treatment Market Size (2014-2019)
10.2 Ankylosing Spondylitis Treatment Key Players in India
10.3 India Ankylosing Spondylitis Treatment Market Size by Type
10.4 India Ankylosing Spondylitis Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Ankylosing Spondylitis Treatment Market Size (2014-2019)
11.2 Ankylosing Spondylitis Treatment Key Players in Central & South America
11.3 Central & South America Ankylosing Spondylitis Treatment Market Size by Type
11.4 Central & South America Ankylosing Spondylitis Treatment Market Size by Application

12 International Players Profiles
12.1 Abbvie
12.1.1 Abbvie Company Details
12.1.2 Company Description and Business Overview
12.1.3 Ankylosing Spondylitis Treatment Introduction
12.1.4 Abbvie Revenue in Ankylosing Spondylitis Treatment Business (2014-2019)
12.1.5 Abbvie Recent Development
12.2 Amgen
12.2.1 Amgen Company Details
12.2.2 Company Description and Business Overview
12.2.3 Ankylosing Spondylitis Treatment Introduction
12.2.4 Amgen Revenue in Ankylosing Spondylitis Treatment Business (2014-2019)
12.2.5 Amgen Recent Development
12.3 Janssen Biotech
12.3.1 Janssen Biotech Company Details
12.3.2 Company Description and Business Overview
12.3.3 Ankylosing Spondylitis Treatment Introduction
12.3.4 Janssen Biotech Revenue in Ankylosing Spondylitis Treatment Business (2014-2019)
12.3.5 Janssen Biotech Recent Development
12.4 Merck
12.4.1 Merck Company Details
12.4.2 Company Description and Business Overview
12.4.3 Ankylosing Spondylitis Treatment Introduction
12.4.4 Merck Revenue in Ankylosing Spondylitis Treatment Business (2014-2019)
12.4.5 Merck Recent Development
12.5 UCB
12.5.1 UCB Company Details
12.5.2 Company Description and Business Overview
12.5.3 Ankylosing Spondylitis Treatment Introduction
12.5.4 UCB Revenue in Ankylosing Spondylitis Treatment Business (2014-2019)
12.5.5 UCB Recent Development
12.6 Boehringer Ingelheim
12.6.1 Boehringer Ingelheim Company Details
12.6.2 Company Description and Business Overview
12.6.3 Ankylosing Spondylitis Treatment Introduction
12.6.4 Boehringer Ingelheim Revenue in Ankylosing Spondylitis Treatment Business (2014-2019)
12.6.5 Boehringer Ingelheim Recent Development
12.7 Johnson & Johnson
12.7.1 Johnson & Johnson Company Details
12.7.2 Company Description and Business Overview
12.7.3 Ankylosing Spondylitis Treatment Introduction
12.7.4 Johnson & Johnson Revenue in Ankylosing Spondylitis Treatment Business (2014-2019)
12.7.5 Johnson & Johnson Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details